The potential of lab-grown meat has captured the imagination of investors, researchers, and consumers alike. In the late 1990s, Willem van Eelen was the first applicant to file the first patent for a cultured meat manufacturing method. Although the lab-grown meat industry has only existed for about 25 years, 2020 was a turning point because a cultured chicken product developed by the company “Eat Just” made its debut at a restaurant menu in Singapore. [Read more…]
Cultured meat refers to meat created using cell culture techniques within a laboratory or manufacturing facility. It is produced by growing master cells collected from cattle, chicken, pigs, fish, lamb, and other livestock. Cultured meat is ethically produced, because livestock is not used within the manufacturing processes beyond collecting the initial cells required for cell culture. [Read more…]
This article explores leading stem cell centers within the U.S. and worldwide. Read on to learn about this emerging area of medicine. [Read more…]
Lab-grown meat is fast becoming a real alternative to its farm-grown counterpart as billionaire entrepreneurs and industry heavyweights invest into start-ups from across the nascent field of “cellular agriculture”. Produced via stem cells derived from cows, pigs, fish, sheep, or other livestock, the emerging clean meat industry has the potential to transform the global food market and create a new trillion dollar industry in the process. [Read more…]
Without question, some of BioInformant’s most popular content has been our interviews with key opinion leaders (KOL). Highlighted below are five interviews that have been widely shared across the stem cell industry. The first interview with Dr. Sadiq has gotten more than 2,200 shares on social media, so you definitely need to check it out. Enjoy!
Stem Cell Therapy Shows Promise for Treatment of MS – Q&A with Dr. Sadiq of the Tisch MS Research Center of NY
In breaking news from the Tisch MS Research Center of New York, Dr. Sadiq announced he is pursuing a Phase II clinical trial exploring the use of stem cells in the treatment of MS. The announcement followed positive results from a FDA-approved Phase I stem cell trial in which MS patients received multiple spinal injections of neural progenitors derived from bone marrow mesenchymal stem cells (called MSC-NPs). Compellingly, it was the first time ever that a treatment method has demonstrated reversal of established disability in MS patients. [Read more…]